Nephrol Dial Transplant (2018) 33: 1280 doi: 10.1093/ndt/gfy135 Advance Access publication 11 May 2018 Erratum Claire C.J. Dekkers, David C. Wheeler, C. David Sjo¨stro¨m, Bergur V. Stefansson, Valerie Cain and Hiddo J.L. Heerspink Effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b–4 chronic kid- ney disease, Nephrology Dialysis Transplantation, gfx350, https://doi.org/10.1093/ndt/gfx350 In the above article, the n numbers for the least squares mean values (LSM) reported below figure 2A were incorrect. The num- bers for Week 102 were repeated under the graph rather than displaying the true LSM values, which were 62 for placebo, 55 for dapa- gliflozin 5 mg and 85 for dapagliflozin 10 mg. The authors apologise for the error which has been corrected. The Author(s) 2018. Published by Oxford University Press on behalf of ERA-EDTA. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial Downloaded from https://academic.oup.com/ndt/article-abstract/33/7/1280/4995217 re-use, please contact email@example.com 1280 by Ed 'DeepDyve' Gillespie user on 03 July 2018 ERRATUM
Nephrology Dialysis Transplantation – Oxford University Press
Published: May 11, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera